Beyond bispecificity: Controlled Fab arm exchange for the generation of antibodies with multiple specificities

Controlled Fab arm exchange (cFAE) has proven to be a generic and versatile technology for the efficient generation of IgG-like bispecific antibodies (DuoBodies or DBs), with several in clinical development and one product, amivantamab, approved by the Food and Drug Administration. In this study, we...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Desislava Yanakieva (Συγγραφέας), Lukas Pekar (Συγγραφέας), Andreas Evers (Συγγραφέας), Markus Fleischer (Συγγραφέας), Stephan Keller (Συγγραφέας), Dirk Mueller-Pompalla (Συγγραφέας), Lars Toleikis (Συγγραφέας), Harald Kolmar (Συγγραφέας), Stefan Zielonka (Συγγραφέας), Simon Krah (Συγγραφέας)
Μορφή: Βιβλίο
Έκδοση: Taylor & Francis Group, 2022-12-01T00:00:00Z.
Θέματα:
Διαθέσιμο Online:Connect to this object online.
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
Περιγραφή
Περίληψη:Controlled Fab arm exchange (cFAE) has proven to be a generic and versatile technology for the efficient generation of IgG-like bispecific antibodies (DuoBodies or DBs), with several in clinical development and one product, amivantamab, approved by the Food and Drug Administration. In this study, we expand the cFAE-toolbox by incorporating VHH-modules at the C-termini of DB-IgGs, termed DB-VHHs. This approach enables the combinatorial generation of tri- and tetraspecific molecules with flexible valencies in a straightforward fashion. Using cFAE, a variety of multispecific molecules was produced and assessed for manufacturability and physicochemical characteristics. In addition, we were able to generate DB-VHHs that efficiently triggered natural killer cell mediated lysis of tumor cells, demonstrating the utility of this format for potential therapeutic applications.
Περιγραφή τεκμηρίου:1942-0862
1942-0870
10.1080/19420862.2021.2018960